BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 36872912)

  • 1. Pulmonary sarcoidosis complicated by rheumatoid arthritis in a patient presenting with progressive fibrosing interstitial lung disease and treated with nintedanib: a case report and literature review.
    Suzuki A; Kamio K; Takeno M; Terasaki Y; Taniuchi N; Sato J; Nishijima N; Saito Y; Seike M; Gemma A; Azuma A
    Ther Adv Respir Dis; 2023; 17():17534666231158279. PubMed ID: 36872912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current perspective of progressive-fibrosing interstitial lung disease.
    Kishaba T
    Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
    Makino S
    Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nintedanib in patients with progressive pulmonary fibrosis associated with rheumatoid arthritis: data from the INBUILD trial.
    Matteson EL; Aringer M; Burmester GR; Mueller H; Moros L; Kolb M
    Clin Rheumatol; 2023 Sep; 42(9):2311-2319. PubMed ID: 37209188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Sarcoidosis Associated with Certolizumab Pegol Treatment for Rheumatoid Arthritis: A Case Report and Review of the Literature.
    Koda K; Toyoshima M; Nozue T; Suda T
    Intern Med; 2020 Aug; 59(16):2015-2021. PubMed ID: 32389943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
    Lamb YN
    Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study.
    Sebastiani M; Venerito V; Laurino E; Gentileschi S; Atzeni F; Canofari C; Andrisani D; Cassone G; Lavista M; D'Alessandro F; Vacchi C; Scardapane A; Frediani B; Cazzato M; Salvarani C; Iannone F; Manfredi A
    J Clin Med; 2023 Nov; 12(22):. PubMed ID: 38002655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of rheumatoid factor and anti-citrullinated peptides in fibrotic interstitial lung disease.
    Zheng B; Donohoe K; Hambly N; Johannson KA; Assayag D; Fisher JH; Manganas H; Marcoux V; Khalil N; Kolb M; Ryerson CJ;
    Respirology; 2022 Oct; 27(10):854-862. PubMed ID: 35652240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive Fibrosing Interstitial Lung Diseases: Prevalence and Characterization in Two Italian Referral Centers.
    Faverio P; Piluso M; De Giacomi F; Della Zoppa M; Cassandro R; Harari S; Luppi F; Pesci A
    Respiration; 2020; 99(10):838-845. PubMed ID: 33264777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
    Schimmelpennink MC; Meek DB; Vorselaars ADM; Langezaal LCM; van Moorsel CHM; van der Vis JJ; Veltkamp M; Grutters JC
    Respir Res; 2022 Jun; 23(1):169. PubMed ID: 35752806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
    Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
    Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure-efficacy analyses of nintedanib in patients with chronic fibrosing interstitial lung disease.
    Schmid U; Weber B; Magnusson MO; Freiwald M
    Respir Med; 2021; 180():106369. PubMed ID: 33798871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic chronic eosinophilic pneumonia associated with noncaseating epithelioid granulomas.
    Shijubo N; Fujishima T; Morita S; Nakata H; Satoh M; Uno E; Morikawa T; Abe S
    Eur Respir J; 1995 Feb; 8(2):327-30. PubMed ID: 7758571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease.
    Tyker A; Ventura IB; Lee CT; Strykowski R; Garcia N; Guzy R; Jablonski R; Vij R; Strek ME; Chung JH; Adegunsoye A
    Sci Rep; 2021 Nov; 11(1):22821. PubMed ID: 34819525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rheumatoid Arthritis-Associated Interstitial Lung Disease: Clinical Characteristics and Predictors of Mortality.
    Hyldgaard C; Ellingsen T; Hilberg O; Bendstrup E
    Respiration; 2019; 98(5):455-460. PubMed ID: 31597131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nintedanib on disease progression and safety in Japanese patients with progressive fibrosing interstitial lung diseases: Further subset analysis from the whole INBUILD trial.
    Ogura T; Suda T; Inase N; Nishioka Y; Azuma A; Okamoto M; Takizawa A; Ito T; Rohr KB; Inoue Y
    Respir Investig; 2022 Nov; 60(6):787-797. PubMed ID: 35927208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nintedanib in Patients With Autoimmune Disease-Related Progressive Fibrosing Interstitial Lung Diseases: Subgroup Analysis of the INBUILD Trial.
    Matteson EL; Kelly C; Distler JHW; Hoffmann-Vold AM; Seibold JR; Mittoo S; Dellaripa PF; Aringer M; Pope J; Distler O; James A; Schlenker-Herceg R; Stowasser S; Quaresma M; Flaherty KR;
    Arthritis Rheumatol; 2022 Jun; 74(6):1039-1047. PubMed ID: 35199968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of sarcoidosis with hypoxia showing slight ground glass opacities on chest CT].
    Isobe Z; Suga T; Aoki Y; Aoki F; Ikeda K; Ueno M; Maeno T; Kurabayashi M; Eishi Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Nov; 46(11):899-903. PubMed ID: 19068763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral pulmonary hilar tumor mass: is it always lung cancer?
    Toma CL; Dumitrache-Rujinski S; Belaconi IN; Paraschiv B; Alexe M; Serbescu A; Leonte D; Bogdan MA
    Maedica (Bucur); 2013 Mar; 8(1):30-3. PubMed ID: 24023595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis, clinical features, and treatment strategy for rheumatoid arthritis-associated interstitial lung disease.
    Akiyama M; Kaneko Y
    Autoimmun Rev; 2022 May; 21(5):103056. PubMed ID: 35121155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.